Gilead Sciences Partners with Veeva Systems to Enhance Customer Management with Vault

In a significant move aimed at fostering technological advancement in the biopharmaceutical sector, Gilead Sciences has announced the adoption of Veeva Vault, a state-of-the-art customer management system developed by Veeva Systems. This partnership highlights Gilead's commitment to innovation in biomedicine, especially in addressing critical health issues such as virology, inflammation, and oncology.

A Strategic Alliance

Peter Gassner, CEO of Veeva, expressed his excitement about this collaboration, stating, "Gilead is pioneering major scientific breakthroughs in the life sciences field, and we are honored to be one of their strategic partners, extending our collaboration to the Veeva Vault customer management system." This sentiment reflects the shared vision between Gilead and Veeva in pushing the boundaries of medical advancement.

Anna Åsberg, Global IT Director at Gilead Sciences, echoed this enthusiasm, pointing out that they are thrilled to deepen their long-standing partnership with Veeva. She mentioned that both companies hold a profound commitment to advancing medicine, and they are particularly excited about the potential of Veeva AI to enhance commercial execution to new heights.

The Features of Veeva Vault

Veeva Vault is not just any customer management system; it is equipped with advanced AI capabilities that elevate its performance significantly. The system includes diverse AI agents designed for various purposes, including call preparation, text compliance, and voice ordering. These features aim to boost efficiency and commercial performance, making it a vital tool in Gilead's operational arsenal.

The Vault CRM system is part of a comprehensive suite of applications that underscore its role as the backbone of commercial execution. With the integration of Veeva AI, the Vault CRM promises to streamline processes and enhance the overall productivity of Gilead's teams.

Gilead Sciences: A Pioneer in Pharmaceuticals

With over three decades of experience, Gilead Sciences has continuously strived to make a significant impact in medical science. The company has been at the forefront of many critical medical breakthroughs, particularly in the development of innovative medications aimed at treating serious diseases like HIV, hepatitis, COVID-19, cancer, and inflammatory conditions. Headquartered in Foster City, California, Gilead operates in more than 35 countries, maintaining a global presence in the healthcare landscape.

Gilead's relentless pursuit of innovation not only demonstrates their dedication to patient care but also highlights their proactive approach in adopting contemporary technologies that support their mission. By investing in Veeva's Vault CRM, Gilead is ensuring that they remain competitive and effective in delivering life-changing therapies to those in need.

Looking Ahead

This collaboration between Gilead Sciences and Veeva Systems represents a forward-thinking approach in the life sciences industry, where technology and healthcare intersect. As they leverage Veeva’s offerings, both companies are poised to redefine what it means to deliver effective and innovative healthcare solutions.

In conclusion, with the backing of Veeva Vault's sophisticated capabilities, Gilead Sciences is well-positioned to continue its legacy of medical breakthroughs, ultimately contributing to a healthier world for everyone. The integration of AI into customer management processes signifies a new era in the biopharmaceutical industry, demonstrating how strategic partnerships can lead to exceptional advancements in healthcare delivery.